Loading...
Dual specificity phosphatase-1 as a pharmacogenetic modifier of inhaled steroid response among asthma patients
BACKGROUND: Inhaled corticosteroids (ICS) are considered first-line treatment for persistent asthma; yet, there is significant variability in treatment response. Dual specificity phosphatase-1 (DUSP1) appears to mediate the anti-inflammatory action of corticosteroids. OBJECTIVE: To determine whether...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2943151/ https://ncbi.nlm.nih.gov/pubmed/20673984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2010.06.007 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|